(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 1.77% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Sight Sciences's revenue in 2025 is $79,866,000.On average, 4 Wall Street analysts forecast SGHT's revenue for 2025 to be $3,697,083,287, with the lowest SGHT revenue forecast at $3,677,525,531, and the highest SGHT revenue forecast at $3,721,620,315. On average, 4 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,191,057,802, with the lowest SGHT revenue forecast at $4,148,195,002, and the highest SGHT revenue forecast at $4,245,213,794.
In 2027, SGHT is forecast to generate $4,859,871,472 in revenue, with the lowest revenue forecast at $4,714,394,617 and the highest revenue forecast at $5,070,746,179.